The reasons were multifold, and I believe that you should ask AstraZeneca for a clear explanation of that. For my part, I believe it had to do with the scale of production that would be required in terms of building up Canadian manufacturing.
Perhaps François-Philippe can jump in here if he wishes.
Certainly, I was raising the point that you are raising now, which is that we would like to be able to manufacture here in Canada.